Netherlands· NL-7991b1008ffc

Lamisil once 1%, oplossing voor cutaan gebruik 10 mg/g

A terbinafine product containing terbinafinehydrochloride, registered in Netherlands by Karo Healthcare AB. The same ATC class is registered in 12 of our 19 countries.

ATC D01AE15

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about terbinafinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Terbinafine is registered in 12 of 19 countries.

Countries holding a registration under ATC D01AE15 (terbinafine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search terbinafine products by name

Terbinafine · ATC D01AE15

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of terbinafine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Terbinafine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.14

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TERBINAFINEHYDROCHLORIDE
Manufacturer: Karo Healthcare AB
Country: Netherlands (NL)
ATC code: D01AE15
ATC class: Terbinafine
Defined daily dose: 10 mg, T
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
33714

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

359 interactions on record for terbinafine.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check terbinafine against other medicines How interaction checks work

Terbinafine · interactions on record

359 records

16 severe
128 moderate
11 minor
202 info

Most severe, free to view

EliglustatA16AX10severe
MipomersenC10AX11severe
LomitapideC10AX12severe
PexidartinibL01EX15severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Terbinafine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terbinafine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Amykal, Lamisil
Belgium · Lamisil, Lamisil Dermgel
Bulgaria · Exoterbyn, Ербинол
Cyprus · Chemiderm, Chemiderm Τοπικό Αντιμυκnτιασικό Φάρμακο
Czechia · Lamisil, Terbinafin Actavis
Germany · Fungizid Extra, Lamisil
Denmark · Finigen, Lamisil
Estonia · Exotafin, Lamisil
Spain · Lamisil, Pevaryl Uñas
Finland · Fungorin, Lamisil
France · Fungster, Lamisil
United Kingdom (Northern Ireland) · Boots Athlete's Foot, Lamisil
Greece · Anaplas, Chemiderm
Croatia · Atere, Exoterbyn
Hungary · Exoterbyn, Lamisil Derma
Ireland · Fungasil, Lamisil
Iceland · Lamisil, Lamisil Once
Italy · Lamisil, Micutan
Lithuania · Lamisil, Lamisil Dermgel
Luxembourg · Lamisil, Lamisil Dermgel
Latvia · Exotafin, Lamisil
Malta · Fungasil, Fungasil 250mg Tablets
Norway · Lamisil, Lamisil Dermgel
Poland · Erfin, Lamisilatt
Portugal · Fungur, Lamisil
Romania · Exoterfyn, Fungisil Mk
Sweden · Azurifin, Lamisil
Slovenia · Exoter, Lamisil
Slovakia · Exoterin, Lamisil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9c24d7e2-6985-4414-a77b-133f49950ef1
GET /v1/drugs/9c24d7e2-6985-4414-a77b-133f49950ef1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor cutaan gebruik",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h33714_smpc.pdf",
  "strength": null,
  "atc_label": "Terbinafine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg33714",
  "excipients": [
    "COPOLYMEER VAN ISOBUTYLMETHACRYLAAT, T-OCTYLACRYLAMIDE EN ACRYLZUUR",
    "ETHANOL 96 %",
    "HYPROLOSE (E 463)",
    "TRIGLYCERIDEN MIDDELLANGE KETEN"
  ],
  "substances": [
    "TERBINAFINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h33714.pdf",
  "authorised_at": "2006/07/12",
  "procedure_number": "SE/H/0992/004",
  "dispensing_status": "Algemene verkoop Naar aanleiding van een additionele beoordeling",
  "registration_number": "33714",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about terbinafine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console